Hongyong Deng

ORCID: 0000-0001-6438-198X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Traditional Chinese Medicine Studies
  • Healthcare and Venom Research
  • Acupuncture Treatment Research Studies
  • Schizophrenia research and treatment
  • Mental Health and Psychiatry
  • Phytoestrogen effects and research
  • Laser Applications in Dentistry and Medicine
  • Liver Disease Diagnosis and Treatment
  • Medical Research and Treatments
  • Clinical practice guidelines implementation
  • Traditional Chinese Medicine Analysis
  • Psychosomatic Disorders and Their Treatments
  • Medicinal Plant Pharmacodynamics Research
  • Alcohol Consumption and Health Effects
  • Ginkgo biloba and Cashew Applications
  • Menopause: Health Impacts and Treatments
  • Cardiovascular Health and Disease Prevention
  • Liver Disease and Transplantation
  • Lung Cancer Treatments and Mutations
  • Physical Activity and Health
  • Parkinson's Disease Mechanisms and Treatments
  • Metabolomics and Mass Spectrometry Studies
  • Bee Products Chemical Analysis
  • Dermatologic Treatments and Research
  • Nephrotoxicity and Medicinal Plants

Shanghai University of Traditional Chinese Medicine
2014-2025

Army Medical University
2024

Xinqiao Hospital
2024

South China Institute of Collaborative Innovation
2022

Ministry of Education of the People's Republic of China
2019

Sartorius (United States)
2017

Shanghai University
2009-2017

Guiyang College of Traditional Chinese Medicine
2012

Diabetic retinopathy (DR) is a leading cause of vision impairment and blindness among individuals with diabetes. Traditional Chinese medicine (TCM) has been explored as an alternative treatment for DR, but the quality evidence remains uncertain. A comprehensive mapping study necessary to synthesize existing SRs, identify gaps in literature, highlight areas requiring further research. This aims evaluate reporting methodological SRs on TCM DR assess effectiveness interventions using...

10.1186/s13643-025-02755-w article EN cc-by-nc-nd Systematic Reviews 2025-02-20

Background: Olaparib, a potent oral poly (ADP-ribose) polymerase inhibitor, exhibits antitumor activity and prevents the recurrence in advanced ovarian cancer. In this article, we assessed efficacy safety of olaparib maintenance therapy on platinum-sensitive cancer patients with BRCA mutations through meta-analysis available randomized controlled trials (RCTs) to provide more evidence for its clinical applications. Methods: We searched PubMed, Embase, Wanfang, CNKI, Web Science, Cochrane...

10.2147/cmar.s191107 article EN cc-by-nc Cancer Management and Research 2019-04-01

To describe the key systems used for Traditional Chinese Medicine (TCM) classification. The TCM classifications in International Classification of Diseases-9 Clinical Modification (ICD-9-CM) volume 3, ICD-10 Procedure Coding System, Health Interventions, and Medical Subject Headings (MeSH) Materia Medica (TCMeSH) thesauruses were compared regarding descriptive terms, structure, features interventions. National Library Medicine's MeSH thesaurus is ubiquitous. ICD-9-CM (volume 3),...

10.1016/j.jtcm.2018.04.003 article EN other-oa Deleted Journal 2018-04-01

10.1093/schbul/sbw114 article EN Schizophrenia Bulletin 2016-08-12

<title>Abstract</title> Objective The aim of this study was to assess the global impact low physical activity (LPA) on stroke using data from Global Burden Disease (GBD) in 2021 and projections 2030. Methods Metrics calculated included disability-adjusted life years (DALYs), age-standardized death rate (ASDR), mortality rates (ASMR). We also performed frontier analyses used Bayesian age-period-cohort models project trends up Results From 1990 2021, ASR due LPA decreased, yet DALYs deaths...

10.21203/rs.3.rs-5347242/v1 preprint EN cc-by Research Square (Research Square) 2024-11-12

Traditional Chinese medicine splenogastric diseases (TCMSDs) are equivalent to digestive system in modern medicine. The forms of clinical evidence TCMSDs include trials, such as randomized controlled trials (RCTs) and systematic reviews (SRs). SRs mainly rely on manual operations have the shortcomings time consumption low efficiency; therefore, they cannot meet needs rapid decision-making. It is urgent establish a new smart form database support progress SRs.

10.1155/2022/6933523 article EN Evidence-based Complementary and Alternative Medicine 2022-07-13

Objectives. We investigated the cognition and application of “Evaluation System Traditional Chinese Medicine Clinical Evidence” among populations with disparate backgrounds. Methods. performed an online survey using a self-designed questionnaire. Results. Of 307 returned questionnaires, 284 were noted to be valid, effective recovery rate was 92.5%. Our analyses showed that respondents demonstrated better understanding clinical evidence-based evaluation systems they used these occasionally....

10.1155/2021/8883921 article EN Evidence-based Complementary and Alternative Medicine 2021-01-21

This study utilized evidence mapping methodology to systematically identify, describe, and evaluate the from relevant research on traditional Chinese medicine(TCM) interventions in patients with pulmonary fibrosis. CNKI, Wanfang, VIP, SinoMed, PubMed, Web of Science, EMbase, Cochrane Library were searched database inception March 2023 for systematic reviews/Meta-analysis/network Meta-analysis TCM The quality included studies was assessed using AMSTAR 2 scale, approach employed present...

10.19540/j.cnki.cjcmm.20230618.501 article EN PubMed 2023-10-01

This study employed a systematic review of randomized clinical trials to evaluate the efficacy and adverse effects Chinese herbal medicine (CHM) for menopausal symptoms. Five electronic databases, including 2 English databases (MEDLINE Cochrane Library) 3 (VIP Database Technical Periodicals, National Knowledge Infrastructure, BioMedical Literature Database) were searched. Thirteen high-quality, randomized, that scored 5 using Jadad scale included. Two thousand two hundred ninety-one...

10.1615/forumimmundisther.v3.i1.70 article EN Forum on Immunopathological Diseases and Therapeutics 2012-01-01
Coming Soon ...